Aramark CEO granted 918 dividend equivalent shares
Aramark’s CEO John J. Zillmer received additional shares via dividend equivalent rights tied to existing equity awards, modestly increasing his direct holdings.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Aramark (ARMK) reported that Chief Executive Officer and director John J. Zillmer acquired 918.023 shares of common stock on September 9, 2026 through a grant of dividend equivalent rights tied to previously granted restricted stock units and performance stock units. Following this award, he holds 1,021,791.73 shares of Aramark common stock directly, with these dividend equivalents vesting on the same schedules as the underlying awards.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 918.023 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on restricted stock units and previously granted performance stock units that were determined to be earned held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.
Key Figures
Key Terms
dividend equivalent rights financial
restricted stock units financial
performance stock units financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Aramark (ARMK) disclose for John J. Zillmer?
What is a dividend equivalent right in the context of Aramark (ARMK)’s Form 4 filing?
Was the Aramark (ARMK) insider transaction made under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.